Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg tumor

Cancer Research and Treatment

Volumn 47, Issue 4, 2015, Pages 697-705

  Cho, Jang Ho ^a   Lim, Jae Yun ^a   Choi, Ah Ran ^a   Choi, Sung Min ^a   Kim, Jong Won ^b   Choi, Seung Ho ^b   Cho, Jae Yong ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Krukenberg tumor; Metastasectomy; Prognosis; Stomach neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS RESECTION; MIDDLE AGED; OVARIECTOMY; OVARY CARCINOMA; OVERALL SURVIVAL; PERITONEAL CARCINOMATOSIS; PERITONEUM CANCER; STOMACH CANCER; TREATMENT OUTCOME; AGED; KRUKENBERG TUMOR; MALE; MULTIMODALITY CANCER THERAPY; OVARIAN NEOPLASMS; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS; SECONDARY; STOMACH TUMOR;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KRUKENBERG TUMOR; MALE; METASTASECTOMY; MIDDLE AGED; OVARIAN NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84946753836     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2013.175     Document Type: Article

References (25)

1. Wang J, Shi YK, Wu LY, Wang JW, Yang S, Yang JL, et al. Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer. 2008;18:825-32.
2. Kim HK, Heo DS, Bang YJ, Kim NK. Prognostic factors of Krukenberg's tumor. Gynecol Oncol. 2001;82:105-9.
3. Petru E, Pickel H, Heydarfadai M, Lahousen M, Haas J, Schaider H, et al. Nongenital cancers metastatic to the ovary. Gynecol Oncol. 1992;44:83-6.
4. Hale RW. Krukenberg tumor of the ovaries: a review of 81 records. Obstet Gynecol. 1968;32:221-5.
5. Duarte I, Llanos O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol. 1981;12:237-42.
6. Saphir O. Signet-ring cell carcinoma. Mil Surg. 1951;109: 360-9.
7. Kim KH, Lee KW, Baek SK, Chang HJ, Kim YJ, Park DJ, et al. Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer. 2011;14:130-8.
8. Cheon SH, Rha SY, Jeung HC, Im CK, Kim SH, Kim HR, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol. 2008;19:1146-53.
9. Elias D, Cavalcanti A, Sabourin JC, Lassau N, Pignon JP, Ducreux M, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol. 1998;24:174-9.
10. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-62.
11. Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE. Liver resection for metastatic colorectal cancer. Surgery. 1986;100:804-10.
12. Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A , Kobayashi A, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol. 2001;96:3178-84.
13. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30:277-99.
14. Ekbom GA, Gleysteen JJ. Gastric malignancy: resection for palliation. Surgery. 1980;88:476-81.
15. Ayhan A, Guvenal T, Salman MC, Ozyuncu O, Sakinci M, Basaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol. 2005;98: 235-41.
16. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol. 1998;69:103-8.
17. Zang RY, Zhang ZY, Li ZT, Chen J, Tang MQ, Liu Q, et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol. 2000;75: 24-30.
18. Kang SB, Park NH, Choi YM, Lee HP. Krukenberg tumors of the ovary: a clinical analysis of 16 cases. J Korean Cancer Assoc. 1990;22:194-201.
19. Lu LC, Shao YY, Hsu CH, Hsu C, Cheng WF, Lin YL, et al. Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. Anticancer Res. 2012;32:3397-401.
20. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol. 2004;94:477-82.
21. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer. J Surg Oncol. 2004;87:39-45.
22. Nio Y, Tsubono M, Kawabata K, Masai Y, Hayashi H, Meyer C, et al. Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for gastric cancer. Ann Surg. 1993; 218:47-53.
23. Al-Agha OM, Nicastri AD. An in-depth look at Krukenberg tumor: an overview. Arch Pathol Lab Med. 2006;130:1725-30.
24. Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, et al. Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 2011;17:1850-7.
25. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993;72:1631-6.